Health Catalyst (HCAT) Enterprise Value (2018 - 2025)
Health Catalyst (HCAT) has disclosed Enterprise Value for 8 consecutive years, with -$91.5 million as the latest value for Q3 2025.
- For the quarter ending Q3 2025, Enterprise Value rose 76.36% year-over-year to -$91.5 million, compared with a TTM value of -$91.5 million through Sep 2025, up 76.36%, and an annual FY2024 reading of -$392.0 million, down 23.38% over the prior year.
- Enterprise Value was -$91.5 million for Q3 2025 at Health Catalyst, up from -$97.3 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$91.5 million in Q3 2025 and bottomed at -$455.2 million in Q3 2021.
- Average Enterprise Value over 5 years is -$332.3 million, with a median of -$347.7 million recorded in 2023.
- The sharpest move saw Enterprise Value plummeted 65.44% in 2021, then surged 76.36% in 2025.
- Year by year, Enterprise Value stood at -$445.0 million in 2021, then increased by 18.31% to -$363.5 million in 2022, then increased by 12.59% to -$317.7 million in 2023, then fell by 23.38% to -$392.0 million in 2024, then soared by 76.65% to -$91.5 million in 2025.
- Business Quant data shows Enterprise Value for HCAT at -$91.5 million in Q3 2025, -$97.3 million in Q2 2025, and -$342.0 million in Q1 2025.